To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06264921
Title A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NiKang Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
AdventHealth Cancer Institute Celebration Florida 34747 United States Details
Augusta University Georgia Cancer Center Augusta Georgia 30909 United States Details
Norton Cancer Institute - Broadway Louisville Kentucky 40202 United States Details
The Gabrail Pharmacology Phase 1 Research Center Canton Ohio 44718 United States Details
Texas Oncology-Austin Midtown NEXT Oncology Austin Texas 78758 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field